Cisplatin-Based Chemotherapy Is a Strong Risk Factor for Thromboembolic Events in Small-Cell Lung Cancer

PURPOSE: Cisplatin-associated arterial and venous thromboembolic events (TEEs) are becoming an increasing concern. In patients with small-cell lung cancer (SCLC) who are treated using cisplatin-based chemotherapy, we assume that the overall risk of TEEs is high. However, cisplatin-associated vascula...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yun-Gyoo, Lee, Eunyoung, Kim, Inho, Lee, Keun-Wook, Kim, Tae Min, Lee, Se-Hoon, Kim, Dong-Wan, Heo, Dae Seog
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614217/
https://www.ncbi.nlm.nih.gov/pubmed/25672586
http://dx.doi.org/10.4143/crt.2014.045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614217/
https://www.ncbi.nlm.nih.gov/pubmed/25672586
http://dx.doi.org/10.4143/crt.2014.045

Ejemplares similares